Strides Pharma Science Limited (NSE:STAR)
1,180.00
-37.00 (-3.04%)
Sep 11, 2026, 3:29 PM IST
Strides Pharma Science Market Cap
Strides Pharma Science has a market cap or net worth of 109.08 billion as of September 11, 2026. Its market cap has increased by 35.64% in one year.
Market Cap
109.08B
Enterprise Value
125.03B
Revenue
50.04B
Ranking
n/a
PE Ratio
17.78
Stock Price
1,180.00
ChartMarket Cap Chart
Since February 2, 2000, Strides Pharma Science's market cap has increased from 7.49B to 109.08B, an increase of 1,355.53%. That is a compound annual growth rate of 10.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 109.08B | 31.44% |
| Dec 31, 2025 | 82.99B | 36.56% |
| Dec 31, 2024 | 60.77B | 1.87% |
| Dec 29, 2023 | 59.66B | 88.83% |
| Dec 30, 2022 | 31.59B | -21.29% |
| Dec 31, 2021 | 40.14B | -49.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eris Lifesciences | 183.56B |
| Cohance Lifesciences | 172.77B |
| Alivus Life Sciences | 168.40B |
| Alembic Pharmaceuticals | 158.92B |
| Sudeep Pharma | 151.83B |
| NATCO Pharma | 147.90B |
| Akums Drugs and Pharmaceuticals | 112.77B |
| Aarti Pharmalabs | 78.60B |